TYPE 1 diabetes lobby group The Danii Foundation has urged the sector to "make your voice heard" by making submissions to a Health Department probe regarding the Freestyle Libre Flash Glucose Monitoring product, to consider its suitability for subsidisation under the National Diabetes Services Scheme (NDSS).
A cost-effectiveness evaluation is being undertaken, with the Danii Foundation warning that the department may recommend additional funding that jeopardises funding for Continuous Glucose Monitoring (CGM) for patients aged over 21.
The Foundation maintains CGM represents better value for money as well as providing the capacity to save lives via its alarm functionality, with the consultation closing on 17 Jul - see health.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Jul 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jul 17
